Amgen Inc
NASDAQ:AMGN

Watchlist Manager
Amgen Inc Logo
Amgen Inc
NASDAQ:AMGN
Watchlist
Price: 292.4 USD -0.35%
Market Cap: 157.2B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
-12%
Revenue
Forecast
+11%
Operating Income
Forecast
+20%
Net Income
Forecast
+25%

Wall Street
Price Targets

AMGN Price Targets Summary
Amgen Inc

Wall Street analysts forecast AMGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AMGN is 320.26 USD with a low forecast of 186.85 USD and a high forecast of 420 USD.

AMGN Lowest Forecast
Wall Street Target
186.85 USD
36% Downside
AMGN Average Forecast
Wall Street Target
320.26 USD
10% Upside
AMGN Highest Forecast
Wall Street Target
420 USD
44% Upside
Lowest
Price Target
186.85 USD
36% Downside
Average
Price Target
320.26 USD
10% Upside
Highest
Price Target
420 USD
44% Upside
Amgen Inc Competitors:
Price Targets
B
377740
BioNote Inc
9% Upside
M
086900
Medy Tox Inc
25% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
68% Upside
MRNA
Moderna Inc
71% Upside
B
377740
BioNote Inc
9% Upside
M
086900
Medy Tox Inc
25% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
68% Upside
MRNA
Moderna Inc
71% Upside
BPMC
Blueprint Medicines Corp
0% Downside
OSE
OSE Immunotherapeutics SA
207% Upside
1530
3SBio Inc
8% Downside
Z
ZBIO
Zenas Biopharma Inc
172% Upside

Revenue
Forecast

Revenue Estimate
Amgen Inc

For the last 8 years the compound annual growth rate for Amgen Inc's revenue is 5%. The projected CAGR for the next 3 years is 4%.

5%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Amgen Inc

For the last 8 years the compound annual growth rate for Amgen Inc's operating income is -4%. The projected CAGR for the next 3 years is 32%.

-4%
Past Growth
32%
Estimated Growth
Estimates Accuracy
-22%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Amgen Inc

For the last 8 years the compound annual growth rate for Amgen Inc's net income is -8%. The projected CAGR for the next 3 years is 45%.

-8%
Past Growth
45%
Estimated Growth
Estimates Accuracy
-32%
Average Miss
What are analyst estimates?

See Also

Summary
AMGN intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMGN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMGN stock valuation using valuation multiples.
Wall Street Estimates
AMGN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMGN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AMGN's stock price target?
Price Target
320.26 USD

According to Wall Street analysts, the average 1-year price target for AMGN is 320.26 USD with a low forecast of 186.85 USD and a high forecast of 420 USD.

What is Amgen Inc's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Amgen Inc's revenue is 5%. The projected CAGR for the next 3 years is 4%.

What is Amgen Inc's Operating Income forecast?
Projected CAGR
32%

For the last 8 years the compound annual growth rate for Amgen Inc's operating income is -4%. The projected CAGR for the next 3 years is 32%.

What is Amgen Inc's Net Income forecast?
Projected CAGR
45%

For the last 8 years the compound annual growth rate for Amgen Inc's net income is -8%. The projected CAGR for the next 3 years is 45%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 261,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.